Delivery Order SPE2DE23D0008-SPE2D626F608D
Award Date 11/18/25
Potential Completion Date 12/3/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,850 fixed-price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical on November 6, 2025, for Natrelle Inspira SSM 405CC breast implants. The contract, which represents a child delivery order under a larger Indefinite Delivery Vehicle (IDV), is scheduled for completion by November 24, 2025, and will be performed at the contractor's facility in Irvine, California. The award carries no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $3,075 delivery order by the Defense Logistics Agency Medical Supply Chain on September 11, 2025, for Natrelle Inspira SSF 485CC breast implants with a completion date of September 15, 2025. This fixed-price contract with economic price adjustment will be performed in Irvine, California and does not utilize a set-aside designation. The award represents a child order under one of Allergan's larger indefinite delivery vehicles,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,814.00 by the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, with an ultimate completion date of July 24, 2025. The contract covers the supply of Natrelle Inspira SCM 375CC breast implants and will be performed in Irvine, California. This award was made without set-aside designation, reflecting Allergan's position as a specialized supplier of these medical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,614.00 fixed-price delivery order on September 19, 2025, for Natrelle Inspira SCM 445CC breast implants through the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract carries an ultimate completion date of September 23, 2025, and will be performed in Irvine, California. This delivery order was issued without set-aside designation, reflecting Allergan's sole-source supplier status for specialized...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $20,856 fixed-price delivery order on October 30, 2025, for Natrelle Inspira SSF 745CC breast implants. This is a child contract under a larger Indefinite Delivery/Indefinite Quantity (IDV) vehicle—a $13.5 million Natrelle breast implants and surgical devices contract established with the Defense Logistics Agency Troop Support Medical on December 8, 2022. The delivery order carries a completion deadline of November 3, 2025, with...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order on September 11, 2025, by the Defense Logistics Agency's Medical Supply Chain division for 4569553905 Inspira SRF 385CC breast implants, valued at $1,110.00. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 25, 2025, and represents performance work to be completed at Allergan's facility in Irvine, California. The award utilizes no set-aside designation,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a $1,200 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain for Natrelle Inspira SSF 325CC breast implants. This delivery order, awarded on July 24, 2025, with an ultimate completion date of July 28, 2025, represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle (IDV) agreements. The contract does not utilize a set-aside designation, reflecting Allergan's position...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,092.00 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division for Inspira SRLP 205CC breast implants. The award, made on September 11, 2025, with an ultimate completion date of September 22, 2025, represents a child delivery order under one of Allergan's larger Indefinite Delivery Vehicle contracts for Natrelle breast implants and surgical devices valued at $13.5 million. The contract utilizes...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $2,814 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 16, 2025, for Natrelle Inspira SCF 605CC breast implants. This delivery order, with an ultimate completion date of September 18, 2025, represents a child contract issued without set-aside designation, reflecting Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The place of...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814.00 fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on November 18, 2025, for Natrelle Inspira SCX 750cc breast implants. The contract, which carries no set-aside designation, is classified as a child order under a larger Indefinite Delivery Vehicle and reflects Allergan's status as a sole-source provider of specialized surgical devices to federal healthcare systems. The delivery order is set to...